v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells

Genes and Development

Volumn 10, Issue 21, 1996, Pages 2720-2731

  Frampton, Jonathan ^a,b   Ramqvist, Torbjörn ^a   Graf, Thomas ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

leukemia; Myb; myeloid cell transformation; programmed cell death

Indexed keywords

PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLAST TRANSFORMATION; BONE MARROW CELL; CHICKEN; GENE CONTROL; MYELOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CELL TRANSFORMATION; VIRUS ONCOGENE;

ANIMALIA; AVES; AVIAN LEUKEMIA VIRUS; GALLUS GALLUS;

EID: 0029844212     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.21.2720     Document Type: Article

References (64)

1. Athanasiou, M., G.J. Mavrothalassitis, C.C. Yuan, and D.G. Blair. 1996. The Gag-Myb-Ets fusion oncogene alters the apoptotic response and growth factor dependence of interleukin-3 dependent murine cells. Oncogene 12: 337-344.
2. Beug, H., M.J. Hayman, and T. Graf. 1982. Myeloblasts transformed by the avian acute leukemia virus E26 are hormone-dependent for growth and for the expression of a putative myb-containing protein, p135 E26. EMBO J. 1: 1069-1073.
3. Beug, H., A. Leutz, P. Kahn, and T. Graf. 1984. Ts mutants of E26 leukemia virus allow transformed myeloblasts, but not erythroblasts or fibroblasts to differentiate at the nonpermissive temperature. Cell 39: 579-588.
4. Beug, H., P. Blundell, and T. Graf. 1987. Reversibility of differentiation and proliferative capacity in avian myelomonocytic cells transformed by tsE26 leukemia virus. Genes & Dev. 1: 277-286.
5. Bies, J. and L. Wolff. 1995. Acceleration of apoptosis in transforming growth factor beta 1-treated M1 cells ectopically expressing B-myb. Cancer Res. 55: 501-504.
6. Burk, O., S. Mink, M. Ringwald, and K.-H. Klempnauer. 1993. Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors. EMBO J. 12: 2027-2038.
7. Cazals-Hatem, D.L., D.C. Louie, S. Tanaka, and J.C. Reed. 1992. Molecular cloning and DNA sequence analysis of cDNA encoding chicken homologue of the Bcl-2 oncoprotein. Biochem. Biophys. Acta. 1132: 109-113.
8. Chomczynski, P. and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidimum thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
9. deWet, J.R., K.V. Wood, M. DeLuca, D.R. Helsinki, and S. Subramani. 1987. Firefly luciferase gene: Structure and expression in mammalian cells. Mol. Cell. Biol. 7: 725-737.
10. Delia, D., A. Aiello, D. Soligo, E. Fontanella, C. Melani, F. Pezzella, M.A. Pierotti, and G.D. Porta. 1992. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79: 1291-1298.
11. Dubendorff, J.W., L.J. Whittaker, J.T. Eltman, and J.S. Lipsick. 1992. Carboxy-terminal elements of c-Myb negatively regulate transcriptional activation in cis and in trans. Genes & Dev. 6: 2524-2535.
12. Eguchi, Y., D.L. Ewert, and Y. Tsujimoto. 1992. Isolation and characterization of the chicken bcl-2 gene: Expression in a variety of tissues including lymphoid and neuronal organs in adult and embryo. Nucleic Acids Res. 20: 4187-4192.
13. Evan, G.I., A.H. Wyllie, C.S. Gilbert, T.D. Littlewood, H. Land, M. Brooks, C.M. Waters, L.Z. Penn, and D.C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128.
14. Fairbairn, L.J., G.J. Cowling, B.M. Reipert, and T.M. Dexter. 1993. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74: 823-832.
15. Ferrao, P., E.M. Macmillan, L.K. Ashman, and T.J. Gonda. 1995. Enforced expression of full length c-Myb leads to density-dependent transformation of murine haematopoietic cells. Oncogene 11: 1631-1638.
16. Frampton, J. and T. Graf. 1996. Myb proteins: Regulators of haemopoietic cell growth, differentiation and apoptosis. In Transcription factors in eukaryotes (ed. A.G. Papavassiliou) R.G. Landes, Austin, TX.
17. Frampton, J., T. Kouzarides, G. Döderlein, T. Graf, and K. Weston. 1993. Influence of the v-Myb transactivation domain on the oncoprotein's transformation specificity. EMBO J. 12: 1333-1341.
18. Frampton, J., K.M. McNagny, M. Sieweke, A. Philip, G. Smith, and T. Graf. 1995. v-Myb DNA binding is required to block thrombocytic differentiation of Myb-Ets-transformed multipotent haematopoietic progenitors. EMBO J. 14: 2866-2875.
19. Frykberg, L., T. Metz, G. Brady, M. Introna, H. Beug, B. Vennström, and T. Graf. 1988. A point mutation in the DNA binding domain of the v-myb oncogene of E26 virus confers temperature sensitivity for transformation of myelomonocytic cells. Oncogene Res. 3: 313-322.
20. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119: 493-501.
21. Golay, J., M. Introna, and T. Graf. 1988. A single point mutation in the v-ets oncogene affects both erythroid and myelomonocytic cell differentiation. Cell 55: 1147-1158.
22. Golay, J., A. Capucci, M. Arsura, M. Castellano, V. Rizzo, and M. Introna. 1991. Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells. Blood 77: 149-158.
23. Gonda, T.J. and D. Metcalf. 1984. Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature 310: 249-251.
24. Graf, T. 1973. Two types of target cells for transformation with avian myelocytomatosis virus. Virology 54: 398-413.
25. Graf, T. 1992. Myb: A transcriptional activator linking proliferation and differentiation in hematopoietic cells. Curr. Opin. Genet. Dev. 2: 249-255.
26. Graf, T., K.M. McNagny, G. Brady, and J. Frampton. 1992. Chicken "erythroid" cells transformed by the Gag-myb-ets encoding E26 leukemia virus are multipotent. Cell 70: 201-213.
27. Ham, J., C. Babij, J. Whitfield, C.M. Pfarr, D. Lallemand, M. Yaniv, and L.L. Rubin. 1995. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14: 927-939.
28. Introna, M., J. Golay, J. Frampton, T. Nakano, S.A. Ness, and T. Graf. 1990. Mutations in v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene. Cell 63: 1287-1297.
29. Jang, S.K., H.-G. Krausslich, M.J.H. Nicklin, G.M. Duke, A.C. Palmenberg, and E. Wimmer. 1988. A segment of the 5′ non-translated region of encephalomyocarditis virus RNA directs internal ribosome entry of ribosomes during in vitro translation. J. Virol. 62: 2636-2643.
30. Kastan, M.B., K.D. Stone, and C.I. Civin. 1989. Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferation status of normal human hematopoietic cells. Blood 74: 1517-1524.
31. Kitada, S., T. Miyashita, S. Tanaka, and J.C. Reed. 1993. Investigations of antisense oligonucleotides targeted against bcl-2 RNAs. Antisense Res. Dev. 3: 157-169.
32. Kraut, N., J. Frampton, K.M. McNagny, and T. Graf. 1994. A functional Ets DNA-binding domain is required to maintain multipotency of hematopoietic progenitors transformed by Myb-Ets. Genes & Dev. 8: 33-44.
33. Lagasse, E. and I.L. Weissman. 1994. bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J. Exp. Med. 179: 1047-1052.
34. Leutz, A., H. Beug, and T. Graf. 1984. Purification and characterization of cMGF, a novel chicken meyelomonocytic growth factor. EMBO J. 3: 3191-3197.
35. Lucas, A. and C. Jamroz. 1961. Atlas of avian hematology. Monograph of the United States Department of Agriculture, Washington, DC.
36. Lüscher, B. and R.N. Eisenman. 1990. New light on MYC and MYB. Part II. MYB. Genes & Dev. 4: 2235-2241.
37. Metz, T. and T. Graf. 1991a. Fusion of the nuclear oncoproteins v-Myb and v-Ets is required for the leukemogenicity of E26 virus. Cell 66: 95-105.
38. _. 1991b. v-myb and v-ets transform chicken erythroid cells and cooperate both in trans and in cis to induce distinct differentiation phenotypes. Genes & Dev. 5: 369-380.
39. Metz, T., T. Graf, and A. Leutz. 1991. Activation of cMGF expression is a critical step in avian myeloid leukemogenesis. EMBO J. 10: 837-844.
40. Miyashita, T. and J. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
41. Miyashita, T., M. Harigai, M. Hanada, and J.C. Reed. 1994a. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54: 3131-3135.
42. Miyashita, T., S. Krajewski, M. Krajewska, H.G. Wang, H.K. Lin, D.A. Liebermann, B. Hoffman, and J.C. Reed. 1994b. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805.
43. Mucenski, M.L., K. McLain, A.B. Kier, S.H. Swederlow, C.M. Schreiner, T.A Miller, D.W. Pietryga, W.J. Scott, Jr., and S.S. Potter. 1991. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65: 677-689.
44. Negrini, M., E. Silini, C. Kozak, Y. Tsujimoto, and C.M. Croce. 1987. Molecular analysis of mbcl-2: Structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma. Cell 49: 455-463.
45. Ness, S.A., A. Marknell, and T. Graf. 1989. The v-myb oncogene product binds to and activates the promyelocytic-specific mim-1 gene. Cell 59: 1115-1125.
46. Ness, S.A., E. Kowenz-Leutz, T. Casini, T. Graf, and A. Leutz. 1993. Myb and NF-M: Combinatorial activators of myeloid genes in heterologous cell types. Genes & Dev. 7: 749-759.
47. Quéva, C., S.A. Ness, F.A. Grässer, T. Graf, B. Vandenbunder, and D. Stéhelin. 1992. Expression patterns of c-myb and of v-myb induced myeloid-1 (mim-1) gene during the development of the chick embryo. Development 114: 125-133.
48. Radke, K., H. Beug, S. Kornfeld, and T. Graf. 1982. Transformation of both erythroid and myeloid cells by E26, an avian leukemia virus that contains the myb gene. Cell 31: 643-653.
49. Reddy, M.A., B.S. Yang, X. Yue, C.J. Bamett, I.L. Ross, M.J. Sweet, D.A. Hume, and M.C. Ostrwski. 1994. Opposing actions of c-ets/PU.1 and c-myb protooncogene products in regulating the macrophage-specific promoters of the human and mouse colony-stimulating factor-1 receptor (c-fms genes). J. Exp. Med. 180: 2309-2319.
50. Roussel, M., S. Saule, C. Lagrou, C. Rommens, H. Beug, T. Graf, and D. Stehelin. 1979. Three new types of viral oncogene of cellular origin specific for haematopoietic cell transformation. Nature 281: 452-455.
51. Sakura, H., C. Kanei-Ishii, T. Nagase, H. Nakagoshi, T.J. Gonda, and S. Ishii. 1989. Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc. Natl. Acad. Sci. 86: 5758-5762.
52. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular cloning: A laboratry manual, 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
53. Selvakumaran, M., H.K. Lin, R.T. Sjin, J.C. Reed, D.A. Liebermann, and B. Hoffman. 1994. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells. Mol Cell. Biol. 14: 2352-2360.
54. Seto, M., U. Jaeger, R.D. Hockett, W. Graninger, S. Bennett, P. Goldman, and S.J. Korsmeyer. 1988. Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J. 7: 123-131.
55. Sgonc, S., G. Boeck, H. Dietrich, J. Gruber, H. Recheis, and G. Wick. 1994. Simultaneous determination of cell surface antigens and apoptosis. Trends Genet. 10: 41-42.
56. Shapiro, L.H. 1995. Myb and Ets proteins cooperate to transactivate an early myeloid gene. J. Biol. Chem. 270: 8763-8771.
57. Shen-Ong, G.L.C. 1990. The myb oncogene. Biochim. Biophys. Acta. 1032: 39-52.
58. Sieweke, M., H. Tekotte, J. Frampton, and T. Graf. 1996 . MafB is an interaction partner and represser of Ets-1 that inhibits erythroid differentiation. Cell 85: 49-60.
59. Smarda, J. and J.S. Lipsick. 1994. c-Myb prevents TPA-induced differentiation and cell death in v-Myb transformed monoblasts. Oncogene 9: 237-245.
60. Taylor, D., P. Badiani, and K. Weston. 1996. A dominant interfering Myb mutant causes apoptosis in T cells. Genes & Dev. (this issue).
61. Westin, E.H., R.C. Gallo, S.K. Arya, A. Eva, L.M. Souza, M.A. Baluda, S.A. Aaronson, and F. Wong-Staal. 1982. Differential expression of the amv gene in human hematopoietic cells. Proc. Natl. Acad. Sci. 79: 2194-2198.
62. Weston, K. 1992. Extension of the DNA binding domain consensus of the chicken c-Myb and v-Myb proteins. Nucleic Acids Res. 20: 3043-3049.
63. White, D.W., A. Roy, and T.D. Gilmore. 1995. The v-Rel oncoprotein blocks apoptosis and proteolysis of I kappa B-alpha in transformed chicken spleen cells. Oncogene 10: 857-868.
64. Young, R.L. and S.J. Korsmeyer. 1993. A negative regulatory element in the bcl-2 5′-untranslated region inhibits expression from an upstream promoter. Mol. Cell. Biol. 13: 3686-3697.